Endomyocardial fibrosis associated with daunorubicin therapy.
A case of endomyocardial fibrosis in a patient with acute myeloblastic leukaemia treated by daunorubicin is reported. The pathological findings are indistinguishable from tropical endomyocardial fibrosis.
D000328:Adult; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D004719:Endomyocardial Fibrosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*
D003561:Cytarabine; D003630:Daunorubicin